Samsung Biologics has promoted Kevin Sharp, head of its New Jersey office leading global sales, to executive vice president, ...

Samsung Biologics has established a corporate social responsibility program that applies 5 to 15 percent of its employees' ...

Samsung Biologics’ workers and management jointly launched a donation program in affiliation with stores and restaurants in ...

Samsung Biologics has introduced a new charity program designed to assist children in need, in cooperation with neighboring ...

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...

On the back of several strong quarters and a year already chock-full of manufacturing accords, Korean CDMO Samsung Biologics ...

Samsung Biologics has secured two deals valued at 930.4 billion won ($668.4 million) with an unnamed European pharmaceutical ...

The global contract development and manufacturing organization ​ (CDMO), Samsung Biologics, announced this week that it has ...

Samsung Biologics has secured a $668 million manufacturing agreement with a European pharma, bringing its total deals for the ...

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' ...

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based pharmaceutical company. This latest deal adds to a string of partnerships ...

Samsung Biologics has now partnered with 17 of the world's top 20 pharmaceutical companies and continues to extend contracts with existing clients to support them in advancing innovative therapies.